Works matching IS 19466234 AND DT 2024 AND VI 16 AND IP 730
Results: 6
Fusion peptide–directed antibodies: Humoral armor against HIV-1 infection.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 730, p. 1, doi. 10.1126/scitranslmed.adl2162
- By:
- Publication type:
- Article
Commensal antimicrobial resistance mediates microbiome resilience to antibiotic disruption.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 730, p. 1, doi. 10.1126/scitranslmed.adi9711
- By:
- Publication type:
- Article
Antibodies targeting the fusion peptide on the HIV envelope provide protection to rhesus macaques against mucosal SHIV challenge.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 730, p. 1, doi. 10.1126/scitranslmed.adh9039
- By:
- Publication type:
- Article
TMEM106B core deposition associates with TDP-43 pathology and is increased in risk SNP carriers for frontotemporal dementia.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 730, p. 1, doi. 10.1126/scitranslmed.adf9735
- By:
- Publication type:
- Article
Small-molecule inhibition of glycogen synthase 1 for the treatment of Pompe disease and other glycogen storage disorders.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 730, p. 1, doi. 10.1126/scitranslmed.adf1691
- By:
- Publication type:
- Article
Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 730, p. 1, doi. 10.1126/scitranslmed.ade2886
- By:
- Publication type:
- Article